|
NL154600B
(nl)
|
1971-02-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
|
|
US3949064A
(en)
|
1973-10-26 |
1976-04-06 |
Baxter Laboratories, Inc. |
Method of detecting antigens or antibodies
|
|
GB1499035A
(en)
|
1975-04-10 |
1978-01-25 |
Ts Nii Gematologii I Perelivan |
Antistaphylococcus human immune globulin and method of preparing same
|
|
US4174384A
(en)
|
1975-06-30 |
1979-11-13 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4367110A
(en)
|
1979-07-02 |
1983-01-04 |
Toppan Printing Co. |
Decorative laminate and a manufacturing method therefor
|
|
US4327082A
(en)
|
1979-07-12 |
1982-04-27 |
Adcock-Ingram Laboratories Limited |
Mastitis vaccination
|
|
US4372945A
(en)
|
1979-11-13 |
1983-02-08 |
Likhite Vilas V |
Antigen compounds
|
|
US4452901A
(en)
|
1980-03-20 |
1984-06-05 |
Ciba-Geigy Corporation |
Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays
|
|
US4338298A
(en)
|
1980-04-04 |
1982-07-06 |
Endowment And Research Foundation At Montana State University |
Vaccine for passive immunization against enteric colibacillosis and method of use
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
IL61904A
(en)
|
1981-01-13 |
1985-07-31 |
Yeda Res & Dev |
Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
|
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
|
US4596792A
(en)
|
1981-09-04 |
1986-06-24 |
The Regents Of The University Of California |
Safe vaccine for hepatitis containing polymerized serum albumin
|
|
NL8200523A
(nl)
|
1982-02-11 |
1983-09-01 |
Univ Leiden |
Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna.
|
|
US4748018A
(en)
|
1984-02-07 |
1988-05-31 |
Stolle Research & Development Corp. |
Method of passive immunization of mammals using avian antibody
|
|
JPS5938877A
(ja)
|
1982-08-30 |
1984-03-02 |
Musashi Eng Kk |
紙葉判別方法
|
|
US5151350A
(en)
|
1982-10-27 |
1992-09-29 |
Repligen Corporation |
Cloned genes encoding recombinant protein a
|
|
US4599230A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4599231A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4879236A
(en)
|
1984-05-16 |
1989-11-07 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
|
US5189015A
(en)
|
1984-05-30 |
1993-02-23 |
Alfa-Laval Agri International Ab |
Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
|
|
US5310687A
(en)
|
1984-10-31 |
1994-05-10 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
|
US5221605A
(en)
|
1984-10-31 |
1993-06-22 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
|
US5238808A
(en)
|
1984-10-31 |
1993-08-24 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
|
US4608251A
(en)
|
1984-11-09 |
1986-08-26 |
Pitman-Moore, Inc. |
LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4601903A
(en)
|
1985-05-01 |
1986-07-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
US5084269A
(en)
|
1986-11-06 |
1992-01-28 |
Kullenberg Fred W |
Adjuvant for dose treatment with antigens
|
|
AU622104B2
(en)
|
1987-03-11 |
1992-04-02 |
Sangtec Molecular Diagnostics Ab |
Method of assaying of nucleic acids, a reagent combination and kit therefore
|
|
US5320951A
(en)
|
1987-06-01 |
1994-06-14 |
Hoeoek Magnus |
Fibronectin binding protein as well as its preparation
|
|
FR2619122B1
(fr)
|
1987-08-03 |
1990-03-09 |
Pasteur Institut |
Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
|
|
US4952500A
(en)
|
1988-02-01 |
1990-08-28 |
University Of Georgia Research Foundation, Inc. |
Cloning systems for Rhodococcus and related bacteria
|
|
US5258494A
(en)
*
|
1988-04-08 |
1993-11-02 |
Stryker Corporation |
Osteogenic proteins
|
|
US5858652A
(en)
|
1988-08-30 |
1999-01-12 |
Abbott Laboratories |
Detection and amplification of target nucleic acid sequences
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
SE8901687D0
(sv)
|
1989-05-11 |
1989-05-11 |
Alfa Laval Agri Int |
Fibronectin binding protein as well as its preparation
|
|
US5302523A
(en)
|
1989-06-21 |
1994-04-12 |
Zeneca Limited |
Transformation of plant cells
|
|
US7705215B1
(en)
|
1990-04-17 |
2010-04-27 |
Dekalb Genetics Corporation |
Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
|
|
US5550318A
(en)
|
1990-04-17 |
1996-08-27 |
Dekalb Genetics Corporation |
Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
|
|
US5322783A
(en)
|
1989-10-17 |
1994-06-21 |
Pioneer Hi-Bred International, Inc. |
Soybean transformation by microparticle bombardment
|
|
US5484956A
(en)
|
1990-01-22 |
1996-01-16 |
Dekalb Genetics Corporation |
Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
|
CA2059692C
(en)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
|
US5199942A
(en)
|
1991-06-07 |
1993-04-06 |
Immunex Corporation |
Method for improving autologous transplantation
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
US5610042A
(en)
|
1991-10-07 |
1997-03-11 |
Ciba-Geigy Corporation |
Methods for stable transformation of wheat
|
|
US5620896A
(en)
|
1992-03-23 |
1997-04-15 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
|
AU667533B2
(en)
|
1992-03-26 |
1996-03-28 |
Microcarb, Inc. |
Monospecific polyclonal antibodies to shiga-like toxins
|
|
ATE398679T1
(de)
|
1992-07-07 |
2008-07-15 |
Japan Tobacco Inc |
Verfahren zur transformation einer monokotyledon pflanze
|
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
|
JP2952041B2
(ja)
|
1992-07-27 |
1999-09-20 |
パイオニア ハイ−ブレッド インターナショナル，インコーポレイテッド |
培養ダイズ細胞のａｇｒｏｂａｃｔｅｒｉｕｍ媒介形質転換の改良法
|
|
DE4228457A1
(de)
|
1992-08-27 |
1994-04-28 |
Beiersdorf Ag |
Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
|
|
EP0621875B1
(en)
|
1992-09-21 |
2002-03-27 |
Alfa-Laval Agri International Ab |
Fibrinogen binding protein
|
|
GB9222888D0
(en)
|
1992-10-30 |
1992-12-16 |
British Tech Group |
Tomography
|
|
US5846709A
(en)
|
1993-06-15 |
1998-12-08 |
Imclone Systems Incorporated |
Chemical process for amplifying and detecting nucleic acid sequences
|
|
FR2708288B1
(fr)
|
1993-07-26 |
1995-09-01 |
Bio Merieux |
Procédé d'amplification d'acides nucléiques par transcription utilisant le déplacement, réactifs et nécessaire pour la mise en Óoeuvre de ce procédé.
|
|
WO1995008348A1
(en)
|
1993-09-22 |
1995-03-30 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
|
|
US5928905A
(en)
|
1995-04-18 |
1999-07-27 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
|
US5648240A
(en)
|
1994-05-24 |
1997-07-15 |
Texas A&M University |
MHC II analog from Staphylococcus aureus
|
|
ATE220424T1
(de)
|
1994-05-28 |
2002-07-15 |
Tepnel Medical Ltd |
Herstellung von nukleinsaeurekopien
|
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
|
US5942391A
(en)
|
1994-06-22 |
1999-08-24 |
Mount Sinai School Of Medicine |
Nucleic acid amplification method: ramification-extension amplification method (RAM)
|
|
FR2722208B1
(fr)
|
1994-07-05 |
1996-10-04 |
Inst Nat Sante Rech Med |
Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
|
|
US6008341A
(en)
|
1994-08-22 |
1999-12-28 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
S. aureus fibrinogen binding protein gene
|
|
US5871986A
(en)
|
1994-09-23 |
1999-02-16 |
The General Hospital Corporation |
Use of a baculovirus to express and exogenous gene in a mammalian cell
|
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
|
US5935825A
(en)
|
1994-11-18 |
1999-08-10 |
Shimadzu Corporation |
Process and reagent for amplifying nucleic acid sequences
|
|
US6770278B1
(en)
|
1994-12-02 |
2004-08-03 |
Central Biomedia, Inc. |
Methods of making and using immunoglobulin (Ig) compositions
|
|
US5548066A
(en)
|
1994-12-02 |
1996-08-20 |
Central Biomedia, Inc. |
Failure of passive transfer immune serum and method of making same
|
|
US5843650A
(en)
|
1995-05-01 |
1998-12-01 |
Segev; David |
Nucleic acid detection and amplification by chemical linkage of oligonucleotides
|
|
WO1997014800A1
(en)
|
1995-10-16 |
1997-04-24 |
Smithkline Beecham Plc |
Novel saliva binding protein
|
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
|
US6833253B2
(en)
|
1996-01-05 |
2004-12-21 |
Human Genome Sciences, Inc. |
Staphylococcus aureus polynucleotides and polypeptides
|
|
US6737248B2
(en)
|
1996-01-05 |
2004-05-18 |
Human Genome Sciences, Inc. |
Staphylococcus aureus polynucleotides and sequences
|
|
US5612473A
(en)
|
1996-01-16 |
1997-03-18 |
Gull Laboratories |
Methods, kits and solutions for preparing sample material for nucleic acid amplification
|
|
FR2746398B1
(fr)
|
1996-03-21 |
1998-04-30 |
Bio Merieux |
Anticorps specifique de staphylococcus aureaus, et utilisations
|
|
US5928906A
(en)
|
1996-05-09 |
1999-07-27 |
Sequenom, Inc. |
Process for direct sequencing during template amplification
|
|
DE69734601T2
(de)
|
1996-05-16 |
2006-08-03 |
The Texas A & M University System, College Station |
Zusammensetzung von kollagenbindungsprotein und verfahren zu deren verwendungen
|
|
US6013763A
(en)
|
1996-06-04 |
2000-01-11 |
Genentech, Inc. |
Peptide variants of protein A
|
|
US5939291A
(en)
|
1996-06-14 |
1999-08-17 |
Sarnoff Corporation |
Microfluidic method for nucleic acid amplification
|
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
|
US6294177B1
(en)
|
1996-09-11 |
2001-09-25 |
Nabi |
Staphylococcus aureus antigen-containing whole cell vaccine
|
|
US5849546A
(en)
|
1996-09-13 |
1998-12-15 |
Epicentre Technologies Corporation |
Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
|
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
|
KR100564268B1
(ko)
|
1996-10-23 |
2006-03-27 |
와이어쓰 |
백신
|
|
US5849497A
(en)
|
1997-04-03 |
1998-12-15 |
The Research Foundation Of State University Of New York |
Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker
|
|
US6610293B1
(en)
|
1997-06-16 |
2003-08-26 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
|
|
US5866366A
(en)
|
1997-07-01 |
1999-02-02 |
Smithkline Beecham Corporation |
gidB
|
|
US5916776A
(en)
|
1997-08-27 |
1999-06-29 |
Sarnoff Corporation |
Amplification method for a polynucleotide
|
|
US6756361B1
(en)
|
1997-10-14 |
2004-06-29 |
Nabi |
Enterococcus antigens and vaccines
|
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
|
US5932451A
(en)
|
1997-11-19 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Method for unbiased mRNA amplification
|
|
US6680195B1
(en)
|
1997-11-26 |
2004-01-20 |
Inhibitex, Inc. |
Extracellular matrix-binding proteins from staphylococcus aureus
|
|
EP1034277B1
(en)
|
1997-11-26 |
2012-06-27 |
Inhibitex, Inc. |
Extracellular matrix-binding proteins from Staphylococcus aureus
|
|
CA2337966A1
(en)
|
1998-07-10 |
2000-01-20 |
U.S. Medical Research Institute Of Infectious Diseases |
Vaccine against staphylococcus intoxication
|
|
EP1121149A4
(en)
|
1998-08-31 |
2002-03-20 |
Inhibitex Inc |
IMMUNOTHERAPEUTICS AGAINST STAPHYLOCOCCUS USING DONOR SELECTION AND DONOR STIMULATION
|
|
JP4714342B2
(ja)
|
1998-08-31 |
2011-06-29 |
ザ プラヴアスト フエロウス アンド スカラース オブ ザ カレツヂ オブ ザ ハリー アンド アンデイヴアイデツド トリニテイ オブ クイーン エリザベス ニヤー ダブリン |
コアグラーゼ陰性スタフィロコカス菌に由来のポリペプチド及びポリヌクレオチド
|
|
US6692739B1
(en)
|
1998-08-31 |
2004-02-17 |
Inhibitex, Inc. |
Staphylococcal immunotherapeutics via donor selection and donor stimulation
|
|
ES2322409T3
(es)
|
1998-08-31 |
2009-06-19 |
Inhibitex, Inc. |
Vacunas multicomponentes contra staphylococcus aureus.
|
|
US6703025B1
(en)
|
1998-08-31 |
2004-03-09 |
Inhibitex, Inc. |
Multicomponent vaccines
|
|
JP2002525083A
(ja)
|
1998-09-01 |
2002-08-13 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ遺伝子およびポリペプチド
|
|
ES2321892T3
(es)
|
1998-09-14 |
2009-06-12 |
Nabi Biopharmaceuticals |
Composiciones de beta-glucanos e inmunoglobulinas especificas.
|
|
AU769539B2
(en)
|
1999-01-29 |
2004-01-29 |
Zoetis Services Llc |
Adjuvants for use in vaccines
|
|
US6936258B1
(en)
|
1999-03-19 |
2005-08-30 |
Nabi Biopharmaceuticals |
Staphylococcus antigen and vaccine
|
|
AU4810600A
(en)
|
1999-04-28 |
2000-11-10 |
Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin, The |
Method of inhibiting leukocyte adhesion to fibrinogen
|
|
WO2000071585A1
(en)
|
1999-05-03 |
2000-11-30 |
Medarex, Inc. |
Human antibodies to staphylococcus aureus
|
|
WO2000069457A1
(en)
|
1999-05-15 |
2000-11-23 |
University Of California, San Diego |
Protein a based binding domains with desirable activities
|
|
WO2001034809A2
(en)
|
1999-11-09 |
2001-05-17 |
Glaxo Group Limited |
Staphylococcus epidermidis nucleic acids and proteins
|
|
ATE413191T1
(de)
|
1999-12-03 |
2008-11-15 |
Celltech Chiroscience Ltd |
Verwendung of interleukin-1 mutein als impfstoffadjuvans
|
|
US6651655B1
(en)
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
SE0000514D0
(sv)
|
2000-02-17 |
2000-02-17 |
Biostapro Ab |
A 52 kDa protein from coagulase negative staphylococci and fragments
|
|
CA2403359A1
(en)
|
2000-03-17 |
2001-09-27 |
Inhibitex, Inc. |
Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use
|
|
CA2404260A1
(en)
|
2000-03-21 |
2001-09-27 |
Elitra Pharmaceuticals, Inc. |
Identification of essential genes in prokaryotes
|
|
GB0014907D0
(en)
|
2000-06-20 |
2000-08-09 |
Univ Sheffield |
Antigenic polypeptides
|
|
SE0003573D0
(sv)
*
|
2000-10-04 |
2000-10-04 |
Bengt Guss |
Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology
|
|
DE60117164T2
(de)
|
2000-11-07 |
2006-08-03 |
Immuno Vaccine Technologies Inc., Halifax |
Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
|
|
AT410798B
(de)
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
US20020169288A1
(en)
|
2001-03-15 |
2002-11-14 |
Magnus Hook |
Collagen-binding adhesin from staphylococcus epidermidis and method of use
|
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
|
US6790448B2
(en)
|
2001-05-08 |
2004-09-14 |
The Texas A&M University System University |
Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them
|
|
MXPA03011701A
(es)
|
2001-06-15 |
2004-12-06 |
Nhibitex Inc |
Anticuerpos monoclonales y policlonales de reaccion que reconocen las proteinas de superficie a partir de estafilococos coagulasa-negativos y staphylococcus aureus.
|
|
CA2351018A1
(en)
|
2001-07-09 |
2003-01-09 |
Universite De Sherbrooke |
Dna vaccine against staphylococcus aureus
|
|
ATE542829T1
(de)
|
2001-08-02 |
2012-02-15 |
Univ Sheffield |
Impfstoff
|
|
US20030113350A1
(en)
|
2001-09-19 |
2003-06-19 |
Fattom Ali I. |
Glycoconjugate vaccines for use in immune-compromised populations
|
|
US7115264B2
(en)
|
2001-11-05 |
2006-10-03 |
Inhibitex |
Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
|
|
WO2003041726A1
(en)
|
2001-11-16 |
2003-05-22 |
Biostapro Ab |
Use of an extracellular adherence protein for the manufacture of an anti-inflammatory drug
|
|
WO2003053462A2
(en)
|
2001-12-11 |
2003-07-03 |
Merck & Co., Inc. |
Staphylococcus aureus exopolysaccharide and process
|
|
EP1481011A4
(en)
|
2002-03-05 |
2007-05-30 |
Inhibitex Inc |
MONOCLONAL AND POLYCLONAL ANTIBODIES THAT DETECT COAGULASENEGATIVE STAPHYLOKOCKE PROTEINS
|
|
US7736652B2
(en)
|
2002-03-21 |
2010-06-15 |
The Regents Of The University Of California |
Antibody fusion proteins: effective adjuvants of protein vaccination
|
|
US6984381B2
(en)
|
2002-07-05 |
2006-01-10 |
The United States Of America As Represented By The Secretary Of Agriculture |
Vaccine for the prevention of bacterial infection of the bovine mammary gland
|
|
EP1540559B1
(en)
|
2002-09-13 |
2013-02-27 |
The Texas A & M University System |
Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
|
|
US20050220788A1
(en)
|
2002-10-03 |
2005-10-06 |
Intercell Ag |
Use of molecules which interact with the haptoglobin receptor ligand binding
|
|
AU2003290867A1
(en)
|
2002-11-12 |
2004-06-03 |
The Brigham And Women's Hospital, Inc. |
Methods and products for treating staphylococcal infections
|
|
PL229487B1
(pl)
|
2002-11-12 |
2018-07-31 |
Brigham & Womens Hospital Inc |
Kompozycja zawierająca polimer β-1,6-glukozaminy, kompozycja zawierająca przeciwciało, kompozycja farmaceutyczna, sposób wytwarzania wyodrębnionego polisacharydu, sposób identyfikacji obecności deacetylowanej poli-N-acetyloglukozaminy (dPNAG) i/ lub poli-N-acetyloglukozaminy (PNAG), wyodrębniony polisacharyd do zastosowania w leczeniu lub profilaktyce zakażenia, wyodrębniony polisacharyd do zastosowania do wytwarzania przeciwciał, w tym przeciwciał monoklonalnych, wyodrębniony polisacharyd do zastosowania w identyfikacji przeciwciała monoklonalnego
|
|
EP1580557A4
(en)
*
|
2002-11-22 |
2006-09-06 |
Daiichi Pure Chemicals Co Ltd |
METHOD FOR THE STUDY OF STAPHYLOCOCCUS AUREUS
|
|
CA2520389A1
(en)
|
2003-03-28 |
2004-10-14 |
Elusys Therapeutics, Inc. |
Method and compositions for conversion of antibody activity
|
|
EP1613642A4
(en)
|
2003-04-16 |
2008-07-02 |
Texas A & M Univ Sys |
EFB PROTEIN OF STAPHYLOCOCCUS AUREUS AND C3 BINDING STAGE THAT INHIBITS COMPLEMENTAL ACTIVATION
|
|
WO2005009378A2
(en)
|
2003-07-24 |
2005-02-03 |
Merck & Co., Inc. |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
KR20060065643A
(ko)
|
2003-07-24 |
2006-06-14 |
머크 앤드 캄파니 인코포레이티드 |
스타필로코쿠스 아우레우스에 대한 방어 면역 반응을유도하는 폴리펩타이드
|
|
US20080160089A1
(en)
|
2003-10-14 |
2008-07-03 |
Medivas, Llc |
Vaccine delivery compositions and methods of use
|
|
US20070134263A1
(en)
|
2004-02-18 |
2007-06-14 |
Anderson Annaliesa S |
Polypeptides for inducing a protective immune response against staphyloococcus aureus
|
|
US20080095792A1
(en)
|
2004-09-17 |
2008-04-24 |
Anderson Annaliesa S |
Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus
|
|
NZ553776A
(en)
|
2004-09-22 |
2010-05-28 |
Glaxosmithkline Biolog Sa |
Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
|
|
AU2005310981A1
(en)
|
2004-10-25 |
2006-06-08 |
The University Of Western Ontario |
Vaccines, compositions and methods based on Staphylococcus aureus iron-regulated surface determinants IsdA, IsdB, and IsdC
|
|
JP2008518947A
(ja)
|
2004-10-29 |
2008-06-05 |
エルシス セラピューティクス， インク． |
免疫応答のクリアランス及び誘導におけるｃｒ１結合分子の使用
|
|
US20060134141A1
(en)
|
2004-12-14 |
2006-06-22 |
Nabi Biopharmaceuticals |
Glycoconjugate vaccines containing peptidoglycan
|
|
US8007806B2
(en)
|
2005-01-20 |
2011-08-30 |
Isconova Ab |
Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide
|
|
US20060228368A1
(en)
|
2005-04-07 |
2006-10-12 |
Nabi Biopharmaceuticals |
Method of protecting against staphylococcal infection
|
|
US8398991B2
(en)
|
2005-06-22 |
2013-03-19 |
Institut Pasteur |
Modified ESAT-6 molecules and improved vaccine strains of Mycobacterium bovis BCG
|
|
GB0526038D0
(en)
|
2005-12-21 |
2006-02-01 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
AU2007281934B2
(en)
*
|
2006-01-18 |
2012-11-15 |
University Of Chicago |
Compositions and methods related to Staphylococcal bacterium proteins
|
|
CA2637152A1
(en)
|
2006-01-27 |
2007-08-09 |
Merck & Co., Inc. |
Antigen-binding proteins targeting s. aureus orf0657n
|
|
WO2007095057A2
(en)
|
2006-02-10 |
2007-08-23 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Use of eap protein for treating and preventing autoimmune neuroinflammatory diseases
|
|
EP1996231A4
(en)
|
2006-02-22 |
2010-09-15 |
Texas A & M Univ Sys |
ANTIBODIES WITH STRONG EXPRESSED PUTATIVE ANTIGEN DETECTION OF CA-MRSA AND METHOD OF USE
|
|
EP2476433A1
(en)
|
2006-03-30 |
2012-07-18 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
AR060187A1
(es)
|
2006-03-30 |
2008-05-28 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica
|
|
US20080131457A1
(en)
|
2006-06-12 |
2008-06-05 |
Nabi Biopharmaceuticals |
Use of alpha-toxin for treating and preventing staphylococcus infections
|
|
CA2667788A1
(en)
|
2006-10-30 |
2008-12-18 |
The University Of Western Ontario |
Staphylococcus aureus specific anti-infectives
|
|
WO2008140487A2
(en)
|
2006-11-14 |
2008-11-20 |
Elusys Therapeutics, Inc. |
Improved staphylococcal protein a mono- and bispecific antibodies and methods of their use
|
|
US7488807B2
(en)
|
2006-11-22 |
2009-02-10 |
3M Innovative Properties Company |
Antibody with protein A selectivity
|
|
US20100047252A1
(en)
|
2006-11-22 |
2010-02-25 |
3M Innovative Properties Company |
Antibody with protein a selectivity
|
|
GB0700136D0
(en)
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
|
WO2009029132A2
(en)
|
2007-05-31 |
2009-03-05 |
Merck & Co., Inc. |
Antigen-binding proteins targeting s. aureus orf0657n
|
|
EP2291196A4
(en)
|
2008-05-12 |
2012-05-30 |
Strox Biopharmaceuticals Llc |
FOR STAPHYLOCOCCUS AUREUS SPECIFIC ANTIBODY PREPARATIONS
|
|
US8592555B2
(en)
|
2008-08-11 |
2013-11-26 |
Emd Millipore Corporation |
Immunoglobulin-binding proteins with improved specificity
|
|
CA2746330C
(en)
|
2008-12-23 |
2017-08-29 |
Genentech, Inc. |
Immunoglobulin variants with altered binding to protein a
|
|
HUE026855T2
(en)
|
2009-04-03 |
2016-07-28 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
|
SA110310528B1
(ar)
|
2009-06-22 |
2014-07-02 |
Wyeth Llc |
التركيبات المولدة للمناعة لأنتيجينات ستافيلوكوكس أوريس
|
|
FR2957821B1
(fr)
|
2010-03-24 |
2014-08-29 |
Inst Francais Du Petrole |
Nouvelle zone de regeneration du catalyseur divisee en secteurs pour unites catalytiques regeneratives
|
|
EP2555794A4
(en)
|
2010-04-05 |
2014-01-15 |
Univ Chicago |
COMPOSITIONS AND METHODS RELATING TO PROTEIN A (SPA) ANTIBODIES AS IMMUNE REACTION AMPLIFIERS
|
|
CA2803298C
(en)
*
|
2010-07-02 |
2020-07-14 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|